Seven Eight Capital, LP Adaptive Biotechnologies Corp Transaction History

Seven Eight Capital, LP

  • $1.05 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$30.02 - $39.87 $286,030 - $379,881
-9,528 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$32.22 - $44.59 $306,992 - $424,853
9,528 New
9,528 $389,000
Q1 2020

May 14, 2020
SELL
$16.96 - $34.16 $118,720 - $239,119
-7,000 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$24.56 - $32.8 $171,920 - $229,599
7,000 New
7,000 $209,000

Others Institutions Holding ADPT

# of Institutions
205
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.14B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email